GKBGKB Ophthalmics Limited
Healthcare · Medical Instruments & Supplies · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
GKB Ophthalmics Limited engages in the manufacture and sale of unfinished ophthalmic lenses in India and internationally. It offers semifinished organic lenses, such as single vision, bifocal, and progressive. The company was incorporated in 1981 and is based in Mapusa, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on GKB — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 31/100)
- • Revenue growth: 2.3% YoY
- • ROE: 2.3%
- • RSI: 41
- • MACD: bearish
Bull case
- • Profit growth: 117.3% YoY
- • Debt/Equity: 0.21
- • Promoter holding: 78.0%
- • Volume trend: 1.4x baseline
Bear case
- • Revenue growth: 2.3% YoY
- • ROE: 2.3%
- • RSI: 41
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Momentum is fading versus the broader market
- • Revenue growth: 2.3% YoY
- • ROE: 2.3%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹4.23). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.